In vitro evaluation of pan-PI3-kinase inhibitor SF1126 in trastuzumab-sensitive and trastuzumab-resistant HER2-over-expressing breast cancer cells

Lignende værker

• Nordihydroguaiaretic Acid, a Cytotoxic IGF-IR/HER2 Inhibitor in Trastuzumab-Resistant Breast Cancer
  af: Rowe, Danica L., et al.
  Udgivet: (2008)
• Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines
  af: Tuba Ozbay, et al.
  Udgivet: (2011-07-01)
• Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines
  af: Ozbay, Tuba, et al.
  Udgivet: (2011)
• Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
  af: Gayle, Sylvia S., et al.
  Udgivet: (2012)
• An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo
  af: De, Pradip, et al.
  Udgivet: (2013)